Content area
Abstract
In the original publication, the text in abstract section under the ‘Results’ section is incorrectly published as ‘higher proportion of patients reached a BeAM value < 55 mg/dL.
Details
Title
Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L
Author
Zisman, Ariel 1 ; Dex, Terry 2 ; Roberts, Michelle 2 ; Saremi, Aramesh 2 ; Chao, Jason 3 ; Aroda, Vanita R. 4
1 Endocrine Center of Aventura, Miami, USA
2 Sanofi US, Inc, Bridgewater, USA (GRID:grid.417555.7) (ISNI:0000 0000 8814 392X)
3 Xinyi, Inc, Bridgewater, USA (GRID:grid.417555.7)
4 Harvard Medical School, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
1 Endocrine Center of Aventura, Miami, USA
2 Sanofi US, Inc, Bridgewater, USA (GRID:grid.417555.7) (ISNI:0000 0000 8814 392X)
3 Xinyi, Inc, Bridgewater, USA (GRID:grid.417555.7)
4 Harvard Medical School, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
First page
327
End page
327
Publication year
2019
Publication date
Feb 2019
ISSN
18696953
e-ISSN
18696961
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2512385575
Copyright
Copyright Springer Nature B.V. Feb 2019